Results 91 to 100 of about 24,656 (219)

Effect of Long-Term Captopril Administration on Bone Density and Orthodontic Tooth Movement

open access: yesJournal of Islamic Dental Association of Iran, 2016
Background and Aim: Captopril is an oral angiotensin-converting-enzyme (ACE) inhibitor extensively used in the treatment of hypertension and heart failure.
Amir Hossein Mirhashemi   +8 more
doaj  

Captopril for prevention of Contrast Induced Nephropathy in patients undergoing Coronary Angioplasty: A double blind placebo controlled clinical trial

open access: yesJournal of Research in Medical Sciences, 2005
Background: Contrast induced nephropathy is a potential cause of mortality and morbidity in patients undergoing angiography–angioplasty. Except for hydrating and probably low – isoosmolar contrast agents in high risk groups, other modalities have not ...
M Hashemi, A Kharazi, S Shahidi
doaj  

Elimination kinetics of captopril in patients with renal failure

open access: yes, 1984
Elimination kinetics of captopril in patients with renal failure. Captopril kinetics were determined after a 100-mg oral dose of14C-captopril in 21 patients with various degrees of renal impairment.
Pierides, Alkis M.   +4 more
core   +1 more source

SUBLINGUAL CAPTOPRIL - A PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION

open access: yes, 1991
In this study we compared the pharmacokinetics and pharmacodynamics of captopril after sublingual and peroral administration. Single 25 mg doses of captopril were administered sublingually and perorally on two different occasions in a randomised cross ...
McElnay, James   +6 more
core  

Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis.

open access: yes, 1990
To date, there is no universally accepted therapy for viral myocarditis. We investigated the effect of the angiotensin converting enzyme inhibitor captopril on both early and late phases of coxsackievirus murine myocarditis.
R A Kloner   +3 more
core   +1 more source

Stability of Extemporaneously Prepared Captopril Solution

open access: yes, 2012
Class of 2012 AbstractSpecific Aims: Assess the stability and sterility of various extemporaneously compounded captopril solution in different storage conditions.
Lee, David, Park, Sean, Wong, Basil
core  

Captopril suppresses interstitial fibrin deposition in coxsackievirus B3 myocarditis

open access: yes, 1997
The effects of captopril on murine coxsackievirus B3 (CB3) myocarditis were investigated, with focus on interstitial fibrin deposition and changes in the connective tissue matrix. Captopril was administered intraperitoneally at a dose of 0.1 mg/g to CB3-
Y. Hiraoka   +5 more
core   +1 more source

Special uses for captopril

open access: yes, 1987
Plasma renin activity (PRA) is markedly increased by captopril. There is not enough separation between the changes in PRA of patients with renal artery stenosis (RAS) to separate them reliably from those with essential hypertension.
Materson, B J
core  

Physicochemical and microbiologicalstabilities of a captopril extemporaneousformulation

open access: yes, 2014
Due to the large number of paediatric patients requiring treatment for hypertension (HT), to the seriousness of its consequences there is a need to prepare an extemporaneous oral captopril formulation suitable for administration to children.
Rafael Coria-Jiménez   +2 more
core   +1 more source

Traitement de la crise hypertensive par le captopril. [Treatment of hypertensive crisis with captopril]

open access: yes, 1983
The usefulness of captopril in managing hypertensive emergencies was evaluated in 9 untreated patients. During the 30 minutes following oral administration of 25 mg of this angiotensin converting enzyme inhibitor, blood pressure decreased from 239/134 to
Schaller, M. D.   +4 more
core  

Home - About - Disclaimer - Privacy